跳至主要内容
临床试验/NCT04156165
NCT04156165已完成不适用

BEEF The Effect of High vs. Moderate Protein Consumption on Human Health - With Beef as Major Source of Protein

University of Copenhagen2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
2
主要终点
Body weight

研究概览

简要总结

The study will be conducted as a parallel randomized controlled intervention trial, initiated by eight weeks rapid weight loss with one of two VLCDs, one week of reintroducing regular foods, and 12 weeks with one of two different ad libitum diets; in total 21 weeks. The study will be blinded for the statistician. Due to obvious different dietary intakes in the two diets, subjects cannot be blinded and neither the study personnel. As the study includes different dietary recommendations the registered clinical dietician advising the subjects cannot be blinded either.

In total 110 overweight and obese volunteers will be included.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy men or women
  • Age, 18-65 years
  • Overweight or grade I-II obesity (BMI 28-40.0 kg/m2)
  • Provided voluntary written informed consent
  • Exclusion Criteria (main:
  • Weight changes ± 5% in the last three months
  • Vegetarian, vegan
  • Pregnancy or lactation, pregnancy within the past 12 month or plans to become pregnant during the study
  • History or diagnosis of diabetes
  • History or diagnosis of heart, liver or kidney disease
  • History or diagnosis of eating disorders
  • Chronic diseases e.g. cancer within the past 5 years (except adequately-treated localized basal cell skin cancer)
  • Simultaneous blood donation for other purpose than this study
  • Simultaneous participation in other clinical intervention studies
  • Use of drugs, that in the opinion of the medically responsible investigator, are likely to affect the outcomes of the study
  • Any other condition that judged by the investigator may interfere with the adherence to the study protocol

排除标准

  • 未提供

结局指标

主要结局

Body weight

时间窗: up to week 21

The subjects will be instructed to stand in the middle of the platform of the scale with a straight neck and eyes looking straight ahead, whilst distributing their weight evenly on both feet. Two measurements are made when the scale has stabilized and both results are noted to the nearest 0.1 kg. The average of the two measurements is used in further analysis.

次要结局

  • Blood pressure(Up to week 21)
  • Fecal samples(Up to week 21)
  • Waist circumference(Up to week 21)
  • Hip circumference(Up to week 21)
  • Body composition(up to week 21)
  • Resting metabolic rate(Up to week 21)
  • Endocrine disruptors(Up to week 21)
  • Glucose metabolism(up to week 21)
  • Inflammation(Up to week 21)
  • Height(Week 0)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Arne Astrup

Professor. Dr.Med

University of Copenhagen

研究点 (2)

Loading locations...

相似试验

The Effect of High vs. Moderate Protein Consumption... | 临床试验